Page last updated: 2024-11-09

cinnamonitrile

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cinnamonitrile: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1550846
CHEMBL ID2387747
SCHEMBL ID23599
MeSH IDM0043268

Synonyms (78)

Synonym
EN300-25436
beta-cyanostyrene
styryl cyanide
4360-47-8
nsc-49137
nsc42118
3-phenyl-2-propenenitrile
3-phenylacrylonitrile
acrylonitrile, 3-phenyl-
nsc49137
wln: nc1u1r
cinnamyl nitrile
nsc-42118
.beta.-cyanostyrene
cinnamonitrile
ai3-28397
nsc 42118
beta-phenylacrylonitrile
einecs 224-441-5
nsc 49137
1-cyano-2-phenylethene
brn 1209545
1-cyano-2-phenylethylene
2-propenenitrile, 3-phenyl-, (e)-
nsc77496
trans-3-phenylpropenonitrile
trans-.beta.-phenylacrylonitrile
(e)3-phenylacrylonitrile
cinnamonitrile, (e)-
1885-38-7
nsc-77496
2-propenenitrile, (e)-
trans-cinnamonitrile
(e)-cinnamonitrile
cinnamonitrile, 97%
zwknlrxfutwsoy-qpjjxvbhsa-
(e)-3-phenylprop-2-enenitrile
inchi=1/c9h7n/c10-8-4-7-9-5-2-1-3-6-9/h1-7h/b7-4+
AKOS000304447
CHEMBL2387747
(e)-3-phenyl-2-propenenitrile
A813237
0-09-00-00589 (beilstein handbook reference)
trans-beta-phenylacrylonitrile
trans-3-phenyl-2-propenenitrile
unii-h475uv3wwh
2-propenenitrile, 3-phenyl-, (2e)-
(e)-3-phenylacrylonitrile
nsc 77496
h475uv3wwh ,
einecs 217-552-5
(2e)-3-phenylprop-2-enenitrile
SCHEMBL23599
cinnamalva
3-phenylpropenenitrile
.beta.-phenylacrylonitrile
NCGC00357077-01
dtxcid6024385
dtxsid8044385 ,
tox21_303789
cas-1885-38-7
7520-75-4
ZWKNLRXFUTWSOY-QPJJXVBHSA-N
(e)-3-phenylpropenenitrile
(2e)-3-phenyl-2-propenenitrile #
J-520051
cinnamonitrile pred. trans
F0001-0677
cinnamonitrile, cis + trans
cinnamonitrilee
J-012148
3-trans-phenyl-acrylonitrile
DS-10164
AMY392
STL563894
Q27279623
CS-0166766
EN300-1703974
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency7.69590.001530.607315,848.9004AID1224841
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1548543Fungicidal activity against fluconazole-resistant Candida albicans assessed as growth inhibition by sub-culturing on Agar plate and incubated for 24 to 48 hrs2020ACS medicinal chemistry letters, Apr-09, Volume: 11, Issue:4
Azole Based Acetohydrazide Derivatives of Cinnamaldehyde Target and Kill
AID750755Inhibition of Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus laevis oocytes assessed as inhibition of MES buffer pH 5.5 -induced currents at 1 mM after 30 secs by voltage clamp technique2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Identification of cinnamic acid derivatives as novel antagonists of the prokaryotic proton-gated ion channel GLIC.
AID1548542Fungicidal activity against fluconazole-susceptible Candida albicans assessed as growth inhibition by sub-culturing on Agar plate and incubated for 24 to 48 hrs2020ACS medicinal chemistry letters, Apr-09, Volume: 11, Issue:4
Azole Based Acetohydrazide Derivatives of Cinnamaldehyde Target and Kill
AID1548540Antifungal activity against fluconazole-susceptible Candida albicans assessed as growth inhibition measured after 24 hrs by CLSI protocol based broth microdilution method2020ACS medicinal chemistry letters, Apr-09, Volume: 11, Issue:4
Azole Based Acetohydrazide Derivatives of Cinnamaldehyde Target and Kill
AID750756Antagonist activity at Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus oocytes assessed as inhibition of MES buffer pH 5.5 -induced currents after 30 secs by voltage clamp technique2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Identification of cinnamic acid derivatives as novel antagonists of the prokaryotic proton-gated ion channel GLIC.
AID1548541Antifungal activity against fluconazole-resistant Candida albicans assessed as growth inhibition measured after 24 hrs by CLSI protocol based broth microdilution method2020ACS medicinal chemistry letters, Apr-09, Volume: 11, Issue:4
Azole Based Acetohydrazide Derivatives of Cinnamaldehyde Target and Kill
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.43 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.44 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]